semaglutide and inflammatory bowel disease & Crohn's Disease: Safety & IBD Considerations – PlexusDx Inflammatory Bowel Disease (IBD): Symptoms,

The most common side effect of GLP-1s is nausea, but we take proactive measures to ensure you go through the program with little to no nausea

Mioduchoski, FNP-BC, under physician supervision at Florida Surgery & Weight Loss Center

Hyperammonemia refers to a clinical condition associated with elevated ammonia levels manifested by a variety of symptoms and signs, including significant central nervous system (CNS) abnormalities

Radosa, M

GLP-1 medications and muscle mass preservation: implications and recommendations

Semaglutide, a GLP-1 receptor agonist, has been revolutionary in managing type 2 diabetes and obesity due to its ability to regulate blood sugar levels and promote weight loss